Language Select
Varian Logo

Press Releases

August 06, 2018
Varian (NYSE: VAR) today announced the acquisition of privately-held humediQ Global GmbH, the manufacturer of IDENTIFY, an automated patient identification, positioning and motion management... Read more
July 25, 2018
Varian (NYSE: VAR) today announced its third quarter fiscal year 2018 results. All comparisons in this announcement are year-over-year unless noted otherwise. Summary (Dollars and shares in... Read more
July 24, 2018
Varian (NYSE: VAR) today announced it will be showcasing its advanced cancer care solutions including a new version of Eclipse™ treatment planning software with support for Halcyon™ 2.0... Read more
June 19, 2018
Varian (NYSE: VAR) today announced the installation of a Varian ProBeam® cyclotron at the proton beam therapy center at University College Hospitals London NHS Foundation Trust (UCLH) in London,... Read more
June 14, 2018
Varian (NYSE: VAR) today announced it received notification from Sirtex Medical Limited (Sirtex) on June 14, 2018 that its board has determined that the proposal from CDH Investments and China... Read more
June 11, 2018
Varian (NYSE: VAR) today announced that it will report results for the third quarter of fiscal year 2018 after market close on Wednesday, July 25, 2018. The news release will be followed by a... Read more
June 05, 2018
Varian (NYSE: VAR) today announced it will be demonstrating its comprehensive portfolio of advanced brachytherapy solutions, June 7-9 in San Francisco, CA at the American Brachytherapy Society... Read more
May 30, 2018
Designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients, treatments with Varian's (NYSE: VAR) Halcyon™ system have... Read more
May 23, 2018
Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, and J. Michael Bruff, senior vice president of investor relations, will present at the Jefferies Global Healthcare... Read more
May 22, 2018
Varian (NYSE: VAR) today announced it received notice from Sirtex Medical Limited (Sirtex) on May 21, 2018 (Pacific daylight time) that the board of directors of Sirtex has now received a binding... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]